21 Nov FUJIFILM Toyama Chemical enters agreement with Appili Therapeutics regard to assigning rights for the development and marketing of T-2307, a candidate compound for the treatment of fungal diseases.

FUJIFILM Toyama Chemical enters agreement with Appili Therapeutics regard to assigning rights for the development and marketing of T-2307, a candidate compound for the treatment of fungal diseases. posted on FujiFilm.com on .

Read the full article on FujiFilm.com
Home




Notice: Undefined variable: qode_like in /sites/fujixnews.com/public/wp-content/themes/bridge/templates/blog-parts/blog-share-like-below-text.php on line 10